Target intelligence / Profile preview

Undecaprenyl-diphosphate–dependent peptidoglycan precursor translocase (MurJ)

Target
MurJ
Molecular classification
Transporter, Flippase, MATE-like superfamily
01

Overview

The Undecaprenyl-diphosphate–dependent peptidoglycan precursor translocase, commonly known as MurJ, is an essential integral membrane protein that functions as a flippase in bacteria (UniProt P0AFG3). It is responsible for transporting Lipid II, the lipid-linked precursor of peptidoglycan, from the cytoplasmic leaflet to the periplasmic leaflet of the inner membrane (Sham et al., 2014, Science). This translocation is a critical step in cell wall biosynthesis, providing the necessary substrates for penicillin-binding proteins to assemble the peptidoglycan layer (Kuk et al., 2017, Nature). Because MurJ is indispensable for bacterial viability and lacks a human ortholog, it is considered a highly promising target for the development of novel antibiotics (Hover et al., 2018, Nature Microbiology). Inhibition of MurJ leads to the accumulation of Lipid II on the inner membrane and the cessation of cell wall synthesis, ultimately resulting in bacterial lysis (Kim et al., 2016, Nature Communications). Recent studies have identified natural products like malacidins and humulimycins that target this pathway, highlighting its therapeutic potential against multidrug-resistant pathogens (Hover et al., 2018; Kim et al., 2016).

Other names
MurJLipid II flippaseMviNPeptidoglycan flippase
02

Mechanism of action

Inhibition of the translocation of Lipid II across the cytoplasmic membrane, preventing cell wall assembly and leading to bacterial lysis.

03

Biological functions

Peptidoglycan biosynthesisCell wall assemblyLipid II transport
04

Disease associations

Infection
05

Safety considerations

Antimicrobial resistanceAlteration of host microbiota
06

Interacting drugs

Humulimycin A

3 more in the full profile.

07

Biomarkers

Lipid II accumulationMinimum inhibitory concentration (MIC)

Beyond the preview

Go deeper on Undecaprenyl-diphosphate–dependent peptidoglycan precursor translocase (MurJ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Undecaprenyl-diphosphate–dependent peptidoglycan precursor translocase (MurJ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call